Spikevax XBB.1.5 Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Andusomeran (COVID-19 mRNA vaccine nucleoside modified)

Indications/Uses

Active immunisation to prevent COVID-19 disease caused by SARS-CoV-2 in individuals ≥12 yr.

Dosage/Direction for Use

IM Individual ≥12 yr 0.5 mL as single dose.

Contraindications

Hypersensitivity.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BN01 - covid-19, RNA-based vaccine ; Belongs to the class of covid-19 vaccines.

Regulatory Classification

POM

Presentation/Packing

Form

Spikevax XBB.1.5 dispersion for inj 50 mcg/0.5ml in pre‐filled syringe

Packing/Price

1's

Form

Spikevax XBB.1.5 dispersion for inj 50 mcg/0.5ml in single-dose vial

Packing/Price

1's

Spikevax XBB.1.5

Manufacturer:

Moderna TX